NOVEL APPROACHES TO TREATING HYPERHIDROSIS ADELAIDE A. HEBERT, MD THE UTHEALTH McGOVERN MEDICAL SCHOOL HOUSTON, TEXAS

Size: px
Start display at page:

Download "NOVEL APPROACHES TO TREATING HYPERHIDROSIS ADELAIDE A. HEBERT, MD THE UTHEALTH McGOVERN MEDICAL SCHOOL HOUSTON, TEXAS"

Transcription

1 DISCLOSURE NOVEL APPROACHES TO TREATING ADELAIDE A. HEBERT, MD THE UTHEALTH McGOVERN MEDICAL SCHOOL HOUSTON, TEXAS WILL DISCUSS OFF LABEL INDICATIONS ALL MONIES FOR RESEARCH WERE PAID TO THE UTHEALTH McGOVERN MEDICAL SCHOOL HOUSTON ADVISORY BOARD DEMIRA GSK DYSAUTONOMIA FINALLY ON THE RADAR SCREEN FOR CLINICAL TRIALS 68 STUDIES LISTED IN clinical trials.gov NOT ALL DEAL WITH DERMATOLOGIC ASPECTS OF THE DISEASE FEW DEAL WITH PEDIATRIC DYSAUTONOMIA DYSAUTONOMIA GROUP OF DISEASES THAT INCLUDE: POSTURAL ORTHOSTATIC SYNDROME (POTS) MULTIPLE SYSTEM ATROPHY AUTONOMIC FAILURE AUTONOMIC NEUROPATHY 1

2 TERAZOSIN IN TREATMENT OF ANTIDEPRESSANT INDUCED ECESSIVE SWEATING TERAZOLIN ALPHA BLOCKER, PERIFERAL USED IN BENIGN PROSTATIC HYPERTROPHY ANTAGONIZES PERIFERAL ALPHA 1 ADRENERGIC RECEPTORS METABOLIZED IN THE LIVER BY CYP450 BOTULINUM TOXIN TYPE A TOPICAL GEL LASER THERAPY 1440 nm LASER ASSISTED SELECTIVE PHOTOTHERMOLYSIS FOR AXILLARY Nd:YAG FOR AXILLARY ULTHERA FOR AXILLARY MIRADRY AXILLARY FRACTIONATED MICRONEEDLE RADIOFREQUENCY FOR TREATMENT OF PRIMARY AXILLARY 2

3 UMECLIDINIUM TOPICAL THERAPY WITH 14 C UMECLIDINIUM DRM04 FOR PRIMARY AXILLARY WIPES MANAGEMENT OF PALMAR WITH HYDROGEL BASED IONTOPHORESIS ANT 1207 FOR PRIMARY AXILLARY OXYBUTININ SYSTEMIC PALMAR PLANTAR LONG TERM USE STUDY OXYBUTININ GEL PRIMARY FOCAL IN ADOLESCENTS AND YOUNG ADULTS 3

4 PRIMARY PEDIATRIC : A REVIEW OF CURRENT TREATMENT OPTIONS GELBARD, C EPSTEIN H, HEBERT AA PEDIATR DERMATOL 2018; 25 (6): SPECIAL CONSIDERATIONS FOR CHILDREN WITH Bohaty BR, Hebert AA Dermatologic Clinics 2014 Oct; 32(4): Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis. Brown AL, Gordon J, Hill S. Curr Opin Pediatr Aug;26(4): Gatto Braganca GM, Lima SO, Pinto Neto AF, Marques LM, et al. An Bras Dermatol. 2014;89(2): PRIMARY CAN LEAD TO MOOOD CHANGES DUE TO THE INCONVENIENCE CAUSED BY THE DISORDER HOSPITAL ANXIETY AND DEPRESSION SCALE 197 PTS 4

5 ANXIETY INCREASED : 49.6% DEPRESSION NOT INCREASED: 11.2% ANXIETY AND DEPRESSION RESULTS: NO LINK TO: GENDER AGE AMOUNT OF AFFECTED AREAS ASSOCIATION NOTED: BETWEEN DEPRESSION AND ANXIETY ANXIETY: MOSTLY MILD TO MODERATE MENTAL HEALTH WORLDWIDE: CAUSE OF DISABILITY: 30.8% OF ALL THE YEARS LIVED WITH THE DISEASE MENTAL HEALTH ANXIETY : MOST COMMON FORM OF MENTAL DISORDER INCIDENCE RATE OF 25 TO 30% MENTAL HEALTH DEPRESSION: FOURTH MOST COMMON CAUSE OF DISABILITY IN THE WORLD SECOND LEADING CAUSE OF INABILITY TO WORK SECOND ONLY TO HEART DISEASE 5

6 IONTOPHORESIS USED SINCE 1930 S USES ELECTRIC CURRENT TO INTRODUCE IONS INTO BODY THROUGH ACROSYRINGIUM WHERE RESISTANCE IS LOWEST IN THE SKIN MAY INVOLVE OBSTRUCTION OF ECCRINE DUCTS IONTOPHORESIS FRED LEVITT, MD LEWIS STOLMAN, MD 83% pts responded favorably USE: MINUTES / SESSION 2 3 X / WEEK THEN MAINTENANCE 1 X / WEEK IONTOPHORESIS IONTOPHORESIS WORKS BEST FOR PALMAR SOME PTS REPORT REDUCTION IN PLANTAR AS WELL HIDREX USA 1 8 HIDREXUSA TOLL FREE 6

7 7

8 WEB SITE 8

HYPERHIDROSIS: THE PEDIATRIC PERSPECTIVE

HYPERHIDROSIS: THE PEDIATRIC PERSPECTIVE HYPERHIDROSIS: THE PEDIATRIC PERSPECTIVE ADELAIDE A. HEBERT, MD PEDIATRIC DERMATOLOGIST THE UTHEALTH McGOVERN MEDICAL SCHOOL HOUSTON, TEXAS WASHINGTON, DC 2017 DISCLOSURE RESEARCH: ALLERGAN, DEMIRA ; ALL

More information

Electric Current Therapy (Iontophoresis) E/I ELECTRIC CURRENT THERAPY (IONTOPHORESIS) HS-237. Policy Number: HS-237. Original Effective Date: 1/9/2014

Electric Current Therapy (Iontophoresis) E/I ELECTRIC CURRENT THERAPY (IONTOPHORESIS) HS-237. Policy Number: HS-237. Original Effective Date: 1/9/2014 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Botulinum Toxin A: Treatment of Hyperhidrosis

Botulinum Toxin A: Treatment of Hyperhidrosis Botulinum Toxin A: Treatment of Hyperhidrosis Dee Anna Glaser, M.D. FAAD Professor Interim Chairman Director of Cosmetic & Laser Surgery Department of Dermatology Professor ENT & Internal Medicine Saint

More information

Clinical Policy: Hyperhidrosis Treatments

Clinical Policy: Hyperhidrosis Treatments Clinical Policy: Reference Number: CP.MP.62 Last Review Date: 02/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Disclosures. Laser Treatment of Scars. Options for Cutaneous Scarring. Laser Treatment of Erythematous Scars. Laser Scar Revision Scar Type

Disclosures. Laser Treatment of Scars. Options for Cutaneous Scarring. Laser Treatment of Erythematous Scars. Laser Scar Revision Scar Type Fundamentals: Instrumentation, and Skin Type Paul M. Friedman, M.D. Director, Dermatology & Laser Surgery Center Clinical Assistant Professor University of Texas Medical School, Houston, TX Clinical Assistant

More information

The prevalence of axillary hyperhidrosis in the

The prevalence of axillary hyperhidrosis in the ORIGINAL ARTICLE Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis H. CHIH-HO HONG, MD, FRCPC,* MARK LUPIN, MD, FRCPC,* AND KATHRYN F. O SHAUGHNESSY, PHD BACKGROUND A third-generation

More information

BACKGROUND There is a paucity of data on the prevalence of multifocal primary hyperhidrosis and changes in hyperhidrosis severity over time.

BACKGROUND There is a paucity of data on the prevalence of multifocal primary hyperhidrosis and changes in hyperhidrosis severity over time. Prevalence of Multifocal Primary Hyperhidrosis and Symptom Severity Over Time: Results of a Targeted Survey Dee Anna Glaser, MD, FAAD,* Angela M. Ballard, RN, BA, EMT, Niquette L. Hunt, BA, Lisa J. Pieretti,

More information

A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis

A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis Pediatric Dermatology Vol. 32 No. 5 69 617, 215 A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis Dee Anna

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hyperhidrosis_treatment_of 9/2004 11/2017 11/2018 11/2017 Description of Procedure or Service Hyperhidrosis

More information

Dermatology Foundation Educational Grant Award to Wisconsin Dermatological Society: Hyperhidrosis Management. Dee Anna Glaser, MD

Dermatology Foundation Educational Grant Award to Wisconsin Dermatological Society: Hyperhidrosis Management. Dee Anna Glaser, MD Dermatology Foundation Educational Grant Award to Wisconsin Dermatological Society: Hyperhidrosis Management Dee Anna, MD Hyperhidrosis: Optimizing Treatment Dee Anna, M.D. Vice Chairman Department of

More information

Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis

Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis Botulin Toxin A prolonged efficacy 395 Original article Clin Ter 2014; 165 (6):e395-400. doi: 10.7417/CT.2014.1780 Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis S. D Epiro,

More information

Presented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX

Presented by: Adelaide A Hebert, MD UTHealth McGovern Medical School, Houston, TX Evaluation of the Efficacy, Safety and Tolerability of 4% Once-Daily in Subjects with Moderate to Severe Acne Vulgaris Treated Topically for Up to 52 Weeks A Hebert, J Del Rosso, M Rico, R Woolson, E de

More information

Botulinum toxin A (Dysport) for hyperhidrosis of the axillae

Botulinum toxin A (Dysport) for hyperhidrosis of the axillae April 2016 Horizon Scanning Research & Intelligence Centre Botulinum toxin A (Dysport) for hyperhidrosis of the axillae LAY SUMMARY This briefing is based on information available at the time of research

More information

Clinical Policy Title: Hyperhidrosis treatment

Clinical Policy Title: Hyperhidrosis treatment Clinical Policy Title: Hyperhidrosis treatment Clinical Policy Number: 16.02.01 Effective Date: September 1, 2013 Initial Review Date: December 10, 2012 Most Recent Review Date: January 11, 2018 Next Review

More information

Kent and Medway Policy Recommendation and Guidance Committee. Policy Recommendation PR : Hyperhidrosis

Kent and Medway Policy Recommendation and Guidance Committee. Policy Recommendation PR : Hyperhidrosis Kent and Medway Policy Recommendation and Guidance Committee. Policy Recommendation PR 2014-06: Hyperhidrosis Recommendation The Kent and Medway Policy Recommendation and Guidance Committee (PRGC) considered

More information

Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial

Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial pissn 1013-9087ㆍeISSN 2005-3894 Ann Dermatol Vol. 29, No. 6, 2017 https://doi.org/10.5021/ad.2017.29.6.728 ORIGINAL ARTICLE Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized,

More information

Palmoplantar hyperhidrosis is usually localized to

Palmoplantar hyperhidrosis is usually localized to Control of Palmar Hyperhidrosis with a New Dry-Type Iontophoretic Device GUN YOEN NA, MD, BYUNG CHEOL PARK, MD, WEON JU LEE, MD, DONG JAE PARK, MD, DO WON KIM, MD AND MYUNG NAM KIM, PHD y BACKGROUND Palmar

More information

Treatment of Dysautonomia in the Joint Hypermobility Syndrome

Treatment of Dysautonomia in the Joint Hypermobility Syndrome Treatment of Dysautonomia in the Joint Hypermobility Syndrome Jaime F. Bravo, MD San Juan de Dios Hospital, Rheumatology Dept. University of Chile Medical School. Santiago, Chile Causes of Dysautonomia

More information

Treatment of Hyperhidrosis

Treatment of Hyperhidrosis Treatment of Hyperhidrosis Policy Number: 8.01.19 Last Review: 8/2018 Origination: 4/2006 Next Review: 8/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for treatment

More information

INVESTIGATION s. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis *

INVESTIGATION s. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis * 230 INVESTIGATION s Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis * Gleide Maria Gatto Bragança 1 Sonia Oliveira Lima 2 Aloisio Ferreira Pinto Neto 2 Lucas

More information

HYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING

HYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING HYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING Version: 1718.v3 Ratified by: SCCG COG Date Ratified: 01 November 2017 Name of Originator/Author: Name of Responsible Committee/Individual: IFR Manager

More information

Clinical Study Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A

Clinical Study Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A ISRN Dermatology, Article ID 308650, 4 pages http://dx.doi.org/10.1155/2014/308650 Clinical Study Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A

More information

Palmar Hyperhidrosis: Long-term Follow-up of Nine Children and Adolescents Treated with Botulinum Toxin Type A

Palmar Hyperhidrosis: Long-term Follow-up of Nine Children and Adolescents Treated with Botulinum Toxin Type A Pediatric Dermatology Vol. 26 No. 4 439 444, 2009 Palmar Hyperhidrosis: Long-term Follow-up of Nine Children and Adolescents Treated with Botulinum Toxin Type A Lúcia H. Coutinho dos Santos, M.D., Ph.D.,

More information

Treatment of Hyperhidrosis

Treatment of Hyperhidrosis Treatment of Hyperhidrosis Policy Number: Original Effective Date: MM.06.015 09/14/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 06/22/18 Section: Surgery Place(s) of Service:

More information

Prior Authorization Update: Botulinum Toxins

Prior Authorization Update: Botulinum Toxins Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Efficacy of botulinum toxin type-a (BT-A) in multiple eccrine hydrocystomas

Efficacy of botulinum toxin type-a (BT-A) in multiple eccrine hydrocystomas ORIGINAL ARTICLE Efficacy of botulinum toxin type-a (BT-A) in multiple eccrine hydrocystomas Hossein Kavoussi, MD Assistant professor, Department of dermatology, Kermanshah University of medical sciences,

More information

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis Leon H. Kircik M.D. Clinical Associate Professor of Dermatology Indiana University School of Medicine Mount Sinai Medical Center, New York, NY Physicians Skin Care, PLLC Louisville, KY 1 ICD 10 Codes L82.1

More information

Treatment of Hyperhidrosis

Treatment of Hyperhidrosis Protocol Treatment of Hyperhidrosis (80119) Medical Benefit Effective Date: 01/01/16 Next Review Date: 11/18 Preauthorization No Review Dates: 03/08, 05/09, 01/10, 01/11, 01/12, 01/13, 01/14, 11/14, 11/15,

More information

p< p< p< (Primary hyperhidrosis)

p< p< p< (Primary hyperhidrosis) (MSc, PT) (PhD, MC) (PhD, PT) (MSc, PT) p< p< p< (Primary hyperhidrosis) e-mail: A_zeinalzade@yahoo.com The Comparison of Efficacy and Persistency of Aluminum J Babol Univ Med Sci; 11(6); Feb-Mar 2010

More information

The Potential Psychological Impact of Skin Conditions

The Potential Psychological Impact of Skin Conditions DOI 10.1007/s13555-016-0169-7 REVIEW The Potential Psychological Impact of Skin Conditions Ari Tuckman Received: August 11, 2016 The Author(s) 2017. This article is published with open access at Springerlink.com

More information

The use of Botulinum Toxin for focal hyperhidrosis life changing and not only cosmetic

The use of Botulinum Toxin for focal hyperhidrosis life changing and not only cosmetic The use of Botulinum Toxin for focal hyperhidrosis life changing and not only cosmetic Abstract Focal hyperhidrosis is the excessive sweating from one part of the body most often the axillae, palms, soles

More information

DRAFT. Medical Coverage Policy Treatment of Hyperhidrosis EFFECTIVE DATE: XXXX POLICY LAST UPDATED: XXXX

DRAFT. Medical Coverage Policy Treatment of Hyperhidrosis EFFECTIVE DATE: XXXX POLICY LAST UPDATED: XXXX Medical Coverage Policy Treatment of Hyperhidrosis EFFECTIVE DATE: XXXX POLICY LAST UPDATED: XXXX OVERVIEW Hyperhidrosis, or excessive sweating, can lead to impairments in psychologic and social functioning.

More information

Is Prophylactic Oxybutynin Safe and Effective in Reducing the Severity of Palmar Hyperhidrosis in Adults?

Is Prophylactic Oxybutynin Safe and Effective in Reducing the Severity of Palmar Hyperhidrosis in Adults? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Is Prophylactic Oxybutynin Safe and Effective

More information

POLICIES AND PROCEDURE MANUAL

POLICIES AND PROCEDURE MANUAL POLICIES AND PROCEDURE MANUAL Policy: MP258 Section: Medical Benefit Policy Subject: Hyperhidrosis I. Policy: Hyperhidrosis II. Purpose/Objective: To provide a policy of coverage regarding Hyperhidrosis

More information

Protocol. / Treatment of Hyperhidrosis

Protocol. / Treatment of Hyperhidrosis / Treatment of Hyperhidrosis Protocol (80119) Medical Benefit Effective Date: 04/01/14 Next Review Date: 01/15 Preauthorization No Review Dates: 03/08, 05/09, 01/10, 01/11, 01/12, 01/13, 01/14 The following

More information

Botulinum Toxin Type A Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives

Botulinum Toxin Type A Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives NHS Dorset Clinical Commissioning Group Botulinum Toxin Type A Criteria Based Access Protocol Supporting people in Dorset to lead healthier lives NHS DORSET CLINICAL COMMISSIONING GROUP BOTULINUM TOXIN

More information

Treatment of Hyperhidrosis

Treatment of Hyperhidrosis Treatment of Hyperhidrosis Policy Number: Original Effective Date: MM.06.015 09/14/2004 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 07/28/2017 Section: Surgery Place(s) of

More information

(head) Use of botulinum toxin to treat hyperhidrosis. (intro) Dr Harry Singh shares with readers how to treat hyperhidrosis using botulinum toxin

(head) Use of botulinum toxin to treat hyperhidrosis. (intro) Dr Harry Singh shares with readers how to treat hyperhidrosis using botulinum toxin (head) Use of botulinum toxin to treat hyperhidrosis (intro) Dr Harry Singh shares with readers how to treat hyperhidrosis using botulinum toxin (biog) Dr Harry Singh BChD MFGDP has been carrying out facial

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Laser Treatment of Port Wine Stains File Name: Origination: Last CAP Review: Next CAP Review: Last Review: laser_treatment_of_port_wine_stains 9/2010 8/2017 8/2018 8/2017 Description

More information

Axillary hyperhidrosis (excessive underarm

Axillary hyperhidrosis (excessive underarm A Randomized, Blinded Clinical Evaluation of a Novel Microwave Device for Treating Axillary Hyperhidrosis: The Dermatologic Reduction in Underarm Perspiration Study DEE ANNA GLASER, MD,* WILLIAM P. COLEMAN,

More information

Hyperhidrosis: A Common Problem

Hyperhidrosis: A Common Problem Preventive Care Abstract : A Common Problem Focal hyperhidrosis is a disorder of idiopathic excessive sweating that typically affects the axillae, soles, palms, and face. This common problem may be associated

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Choudhry NK, Krumme AA, Ercole PM, et al. Effect of reminder devices on medication adherence: the REMIND randomized clinical trial. JAMA Int Med. Published online February

More information

SPECIAL TOPIC. AboutSkin Dermatology & DermSurgery, Greenwood Village, CO b. The Aesthetic Clinique, Destin, FL c

SPECIAL TOPIC. AboutSkin Dermatology & DermSurgery, Greenwood Village, CO b. The Aesthetic Clinique, Destin, FL c November 2016 611 Volume 15 Issue 11 Copyright 2016 ORIGINAL ARTICLES SPECIAL TOPIC Multi-Center Pilot Study to Evaluate the Safety Profile of High Energy Fractionated Radiofrequency With Insulated Microneedles

More information

Topical botulinum toxin to treat hyperhidrosis? No sweat!

Topical botulinum toxin to treat hyperhidrosis? No sweat! Medical Hypotheses (2006) 67, 27 32 http://intl.elsevierhealth.com/journals/mehy Topical botulinum toxin to treat hyperhidrosis? No sweat! Erle C.H. Lim *, Raymond C.S. Seet, Adeline Chow, Vernon M.S.

More information

Application of Botox for Pedal Hyperhydrosis. By Mostafa Niknafs, DPM & Mohsen Khoshneviszadeh, DPM

Application of Botox for Pedal Hyperhydrosis. By Mostafa Niknafs, DPM & Mohsen Khoshneviszadeh, DPM Application of Botox for Pedal Hyperhydrosis By Mostafa Niknafs, DPM & Mohsen Khoshneviszadeh, DPM Dr. Niknafs is Diplomate of ABPS. He completed his medical education is United Kingdom, followed by his

More information

Management of Postsurgical Hyperhidrosis With Direct Current and Tap Water

Management of Postsurgical Hyperhidrosis With Direct Current and Tap Water Marquette University e-publications@marquette Physical Therapy Faculty Research and Publications Physical Therapy, Department of 3-1-2004 Management of Postsurgical Hyperhidrosis With Direct Current and

More information

ADRENERGIC RECEPTOR ANTAGONISTS: ALPHA RECEPTOR BLOCKERS

ADRENERGIC RECEPTOR ANTAGONISTS: ALPHA RECEPTOR BLOCKERS Jack Deuiter, Principles of Drug Action 2, Fall 2000 ADEEGIC ECEPT ATAGISTS: ALPA ECEPT BLCKES General PC/MC: Understand the term "antagonist" and how an antagonist is similar to an agonist, and how an

More information

An alternative to treat palmar hyperhidrosis: use of oxybutynin

An alternative to treat palmar hyperhidrosis: use of oxybutynin Clin Auton Res (2011) 21:389 393 DOI 10.1007/s10286-011-0128-4 RESEARCH ARTICLE An alternative to treat palmar hyperhidrosis: use of oxybutynin Nelson Wolosker Jose R. de Campos Paulo Kauffman Samantha

More information

Hyperhidrosis is a common condition, affecting. ActaDV ActaDV

Hyperhidrosis is a common condition, affecting. ActaDV ActaDV 1120 CLINICAL REPORT Topical Oxybutynin 10% Gel for the Treatment of Primary Focal Hyperhidrosis: A Randomized Double-blind Placebo-controlled Split Area Study Ofir ARTZI 1, Christophoros LOIZIDES 1, Eyal

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

Hyperhidrosis is defined as excessive sweating beyond

Hyperhidrosis is defined as excessive sweating beyond REPORT Examining Hyperhidrosis: An Update on New Treatments Carolyn I. Jacob, MD Hyperhidrosis is defined as excessive sweating beyond what is physiologically required for the body to thermoregulate. 1

More information

Management of LUTS after TURP and MIT

Management of LUTS after TURP and MIT Management of LUTS after TURP and MIT Hong Sup Kim Konkuk University TURP & MIT TURP : Gold standard MIT TUIP TUNA TUMT HIFU LASER Nd:YAG, ILC, HoLRP, KTP LUTS after TURP and MIT Improved : about 70% Persistent

More information

droxidopa (Northera )

droxidopa (Northera ) Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Neuropsychiatric SLE (NPSLE) Dr. MTL NYO FCP(SA), Cert Rheum (Phys) Division of Rheumatology Department of Internal Medicine DGMAH / SMU

Neuropsychiatric SLE (NPSLE) Dr. MTL NYO FCP(SA), Cert Rheum (Phys) Division of Rheumatology Department of Internal Medicine DGMAH / SMU Neuropsychiatric SLE (NPSLE) Dr. MTL NYO FCP(SA), Cert Rheum (Phys) Division of Rheumatology Department of Internal Medicine DGMAH / SMU NPSLE represents a diagnostic and therapeutic challenge Wide range

More information

OBSTETRICS & GYNECOLOGY

OBSTETRICS & GYNECOLOGY JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Female Sexual Arousal

More information

Neuro Basics SLO Practice (online) Page 1 of 5

Neuro Basics SLO Practice (online) Page 1 of 5 Neuro Basics SLO Practice (online) Page 1 of 5 1) Biogenic amines include ACh, NE, EPI and? a) Melatonin b) Dopamine c) Serotonin d) Histamine e) All of the neurotransmitters listed are biogenic amines.

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE

ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE Rev. Med. Chir. Soc. Med. Nat., Iaşi 2014 vol. 118, no. 1 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE Emilia-Lidia

More information

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)? Pharmacy Prior Authorization AETA BETTER HEALTH MICHIGA Botulinum Toxins (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign

More information

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax: Michelle Zetoony, DO, FCCP, FACOI 545 4 th Avenue S, Suite A Phone: 727-826-0933 Fax: 727-826-0744 http://www.dosleep.com SLEEP TALK 9/9 BMJ Open2012 Pharmacology and therapeutics Research What is sleep?

More information

Prostate Health PHARMACIST VIEW

Prostate Health PHARMACIST VIEW Prostate Health PHARMACIST VIEW Prostate Definition Prostate is a gland made of fibromuscular tissue. It is about 4 cm and surrounds the neck of the bladder and the urethra. It produces seminal fluid.

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 5 PURPOSE To assure that DOP inmates with skin lesions are receiving appropriate Primary Care for their lesions POLICY All DOP Primary Care Providers are expected to follow this guideline and/or

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of transcutaneous microwave ablation for severe primary axillary hyperhidrosis Axillary

More information

IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY. Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group

IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY. Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group Who Am I? Avid equestrian Trained in Physical Medicine & Rehabilitation

More information

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dr Rahul Chakor, Associate Prof and Head Dept of Neurology, Dr Anand Soni, Senior Resident, T N Medical

More information

Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population

Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population Original Paper Dermatology 2016;232:586 591 Received: April 28, 2016 Accepted after revision: June 20, 2016 Published online: September 1, 2016 Prevalence and Characteristics of Hyperhidrosis in Sweden:

More information

The Evaluation and Management of Drooling

The Evaluation and Management of Drooling The Evaluation and Management of Drooling Sarah Rodriguez, MD Faculty Advisor: Byron Bailey, MD, FACS The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation January

More information

Myofascial Pain Syndrome and Trigger Points. Paul S. Sullivan, Do Trinity Health Care New England - Family Medicine

Myofascial Pain Syndrome and Trigger Points. Paul S. Sullivan, Do Trinity Health Care New England - Family Medicine Myofascial Pain Syndrome and Trigger Points Paul S. Sullivan, Do Trinity Health Care New England - Family Medicine Objectives Discuss why this topic is pertinent to our practices Review diagnostic criteria

More information

Disclosures. Where We Are Going. My Goals for Giving This Talk. Diagnosis and Management of Dysautonomia in the Pediatric Population

Disclosures. Where We Are Going. My Goals for Giving This Talk. Diagnosis and Management of Dysautonomia in the Pediatric Population Diagnosis and Management of Dysautonomia in the Pediatric Population Disclosures David M Bush, MD, PhD Pediatric Cardiology/Electrophysiology Pediatric Cardiology Associates of San Antonio Adjunct Associate

More information

Blood pressure charts for pediatrics

Blood pressure charts for pediatrics Blood pressure charts for pediatrics Blood pressure screening is essential throughout life. Adult blood pressure assessments have static thresholds of 140/90 for hypertension and 90/60 for hypotension

More information

Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada. Pathogenesis & management of acne scarring

Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada. Pathogenesis & management of acne scarring Jerry Tan MD FRCPC University of Western Ontario Windsor campus, Ontario, Canada Pathogenesis & management of acne scarring Disclosures Relationships with commercial interests: Abbott Laboratories A(Grants/Research

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Laser Treatment of Onychomycosis File Name: Origination: Last CAP Review: Next CAP Review: Last Review: laser_treatment_of_onychomycosis 5/2013 11/2017 11/2018 11/2017 Description

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

Enteral Nutrition in the Critically Ill Child: Challenges and Current Guidelines

Enteral Nutrition in the Critically Ill Child: Challenges and Current Guidelines Enteral Nutrition in the Critically Ill Child: Challenges and Current Guidelines 1 Presented on January 24, 2017 Jorge A. Coss-Bu, MD Associate Professor of Pediatrics Section of Critical Care Baylor College

More information

Free flow of sweat due to loss of surface tension at sweat droplet causes water-induced skin wrinkling

Free flow of sweat due to loss of surface tension at sweat droplet causes water-induced skin wrinkling Free flow of sweat due to loss of surface tension at sweat droplet causes water-induced skin wrinkling Abstract Soumya Marasakatla and Karunakar Marasakatla Water immersion skin wrinkling appears to be

More information

Building a Global Neurotoxin Franchise

Building a Global Neurotoxin Franchise JUNE 2, 2014 Building a Global Neurotoxin Franchise DAN BROWNE President & CEO Forward-Looking Statements This presentation contains forward-looking statements, including statements related to the process

More information

Original Policy Date

Original Policy Date MP 8.01.14 Treatment of Hyperhidrosis Medical Policy Section Therapy Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Reviewed with literature search/12/2013 Return to Medical Policy

More information

Disclosure. Lowell Kabnick, M.D., FACS, FACPh. I disclose the following financial relationship(s):

Disclosure. Lowell Kabnick, M.D., FACS, FACPh. I disclose the following financial relationship(s): Disclosure Lowell Kabnick, M.D., FACS, FACPh I disclose the following financial relationship(s): Research Grant: BTG; Ownership Interest: AngioDynamics, Vascular Insights; Consultant/Advisory Board: AngioDynamics,

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

Efficacy and safety of ablative fractional carbon dioxide laser for acne scars

Efficacy and safety of ablative fractional carbon dioxide laser for acne scars Original Article Efficacy and safety of ablative fractional carbon dioxide laser for acne scars Tahir Jamil Ahmad*, Farhana Muzaffar**, Haroon Nabi *, Sarmad Malik*, Ayesha Noreen*, Rabiya Hayat *Department

More information

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE

POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS) IT S NOT THAT SIMPLE POTS Irritable heart syndrome. Soldier s heart. Effort syndrome. Vasoregulatory asthenia. Neurocirculatory asthenia. Anxiety neurosis.

More information

Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients

Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients Original Article Korean J Pain 2012 January; Vol. 25, No. 1: 28-32 pissn 2005-9159 eissn 2093-0569 http://dx.doi.org/10.3344/kjp.2012.25.1.28 Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients

More information

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of prostate, holmium laser, 485 495 African prune tree (Pygeum africanum), 454 455 Alfuzosin, 445 446 Alpha-adrenergic agonists,

More information

BOTULINUM TOXIN (BOTOX) POLICY HYPERHIDROSIS - PRIOR APPROVAL

BOTULINUM TOXIN (BOTOX) POLICY HYPERHIDROSIS - PRIOR APPROVAL BOTULINUM TOXIN (BOTOX) POLICY HYPERHIDROSIS - PRIOR APPROVAL Version: Ratified by: 1617.v2c SCCG COG Date Ratified: 11 May 2016 Name of Originator/Author: Name of Responsible Committee/Individual: IFR

More information

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา 1 CONTENT 1 2 3 Chronic Daily Headache Medical Overused Headache Management Headaches are one of the most common symptoms List

More information

MEDICAL UPDATES. Chronic fatigue syndrome following infections in adolescents. azithromycin in pediatric patients with CF

MEDICAL UPDATES. Chronic fatigue syndrome following infections in adolescents. azithromycin in pediatric patients with CF MEDICAL UPDATES Issue No.:14 July 2013 Chronic fatigue syndrome following infections in adolescents Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

More information

Partial Unilateral Lentiginosis Treated with 532-nm and Subsequent Low-Fluence 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Lasers

Partial Unilateral Lentiginosis Treated with 532-nm and Subsequent Low-Fluence 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Lasers OCT-2016 ISSUE Med Laser 2016;5(1):42-46 pissn 2287-8300 ㆍ eissn 2288-0224 Partial Unilateral Lentiginosis Treated with 532-nm and Subsequent Low-Fluence 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum

More information

In this issue ALERT: GOOD MORNING AMERICA To Air Segment on Hyperhidrosis Page 2. David M. Pariser, MD, founding Board Member, Takes the Oath

In this issue ALERT: GOOD MORNING AMERICA To Air Segment on Hyperhidrosis Page 2. David M. Pariser, MD, founding Board Member, Takes the Oath From the Executive Director It s a new year and we ve already spotted a trend for hyperhidrosis care in 2009: Raising Awareness. In this edition of SweatSolutions, we have four stories that highlight people

More information

URGE MOTOR INCONTINENCE

URGE MOTOR INCONTINENCE URGE MOTOR INCONTINENCE URGE INCONTINENCE COMMONEST TYPE IN ELDERLY WOMEN Causes: 1 - Defects in CNS regulation Stroke Parkinson s disease Dementia (Alzheimer s and other types) Normopressure hydrocephalus

More information

UCLA-LIVESTRONG LIVESTRONG Survivorship Center of Excellence One in three individuals with receive a cancer diagnosis in their lifetime 10.6 million A

UCLA-LIVESTRONG LIVESTRONG Survivorship Center of Excellence One in three individuals with receive a cancer diagnosis in their lifetime 10.6 million A Cardiovascular Health After Cancer: Common and Overlooked Issues for Post-Cancer Care Barbara Natterson Horowitz, M.D. UCLA Division of Cardiology David Geffen School of Medicine at UCLA UCLA-LIVESTRONG

More information

Evaluation of Parkinson s Patients and Primary Care Providers

Evaluation of Parkinson s Patients and Primary Care Providers Evaluation of Parkinson s Patients and Primary Care Providers 2018 Movement Disorders Half Day Symposium Elise Anderson MD Medical Co-Director, PBSI Movement Disorders 6/28/2018 1 Disclosures GE Speaker,

More information

HPV vaccine perspectives Dr. David Prado Cohrs

HPV vaccine perspectives Dr. David Prado Cohrs HPV vaccine perspectives Dr. David Prado Cohrs Universidad Francisco Marroquín, Guatemala President of the Sexually Transmitted Diseases Committee, SLIPE Disclosure statement The presenter has received

More information

Botulinum Toxins. Length of Authorization: From 90 days to 12 months

Botulinum Toxins. Length of Authorization: From 90 days to 12 months Botulinum Toxins Goal(s): Approve botulinum toxins for funded OHP conditions supported by evidence of benefit (eg, dystonia or spasticity associated with certain neurological diseases). Require positive

More information

Real Deal vs Dust Collector: Lasers & Other Machines for Your Office Karol A Gutowski, MD, FACS

Real Deal vs Dust Collector: Lasers & Other Machines for Your Office Karol A Gutowski, MD, FACS Real Deal vs Dust Collector: Lasers & Other Machines for Your Office Karol A Gutowski, MD, FACS Private Practice Clinical Associate Professor University of Illinois, Chicago Take Home Message Don t buy

More information

June 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE

June 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE June 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE Where to go for help Syncope: HRS Definition Syncope is defined as: a transient loss of consciousness, associated with an inability to maintain postural

More information

Department of Dermatology. (Seoul National University Hospital)

Department of Dermatology. (Seoul National University Hospital) Department of Dermatology (Seoul National University Hospital) 1. Introduction Seoul National University Hospital Department of Dermatology has been proved its excellence both in clinics as well as research.

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21796 holds various files of this Leiden University dissertation. Author: Bruggink, Sjoerd Cristoffel Title: Transmission and treatment of cutaneous warts

More information

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5.

MEDICAL THERAPY. Endocrine Approaches. Página 1 de 5. Página 1 de 5 MEDICAL THERAPY Part of "32 - BENIGN PROSTATIC HYPERPLASIA" Use of pharmacologically defined and a variety of so-called alternative medications to attempt to improve BPH voiding dysfunction

More information